SightfileU.S. market data from official filings

FENNEC PHARMACEUTICALS INC (FENC)

Name: FENNEC PHARMACEUTICALS INC (FENC) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001211583 · EDGAR filings · Updated 2026-07-02

FENNEC PHARMACEUTICALS INC (FENC) has reported institutional ownership of 47.0%, with 90 institutional managers holding positions valued at $99.6M per the latest 13F reporting period.

Institutional ownership

47.0%

Institutional managers

Reported 13F value

$99.6M

Insider activity

68 trans.

−$11.3M net selling

Latest updates

2026-07-02 — Insider transaction reported (Form 4)
2026-07-01 — Insider transaction reported (Form 4)
2026-07-01 — Insider transaction reported (Form 4)
2026-07-01 — Insider transaction reported (Form 4)
2026-07-01 — Insider transaction reported (Form 4)
2026-07-01 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, FENNEC PHARMACEUTICALS INC has 90 institutional holders and institutional ownership of 47.0%.

Insider activity

Insiders reported 68 transactions (2 buys, 23 sells) across 8 reporting insiders, with a net reported value of −$11.3M.

Related companies

SILENCE THERAPEUTICS PLC (SLN) · ZENTALIS PHARMACEUTICALS INC (ZNTL) · COHERUS ONCOLOGY INC (CHRS) · Sol-Gel Technologies Ltd (SLGL) · PEPGEN INC (PEPG) · ORCHESTRA BIOMED HLDGS INC (OBIO)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.